Study reveals acupuncture’s ability to reduce pain: A team of researchers led by Dr. Maiken Nedergaard of the University of Rochester have discovered why acupuncture is able to alleviate pain. Surprisingly, it isn’t all attributable to the placebo effect. In a study published online this weekend in Nature Neuroscience, mice with sore paws were given half-hour acupuncture sessions. The researchers found that rotation of the acupuncture needles damaged tissue, which caused a release of adenosine, a known anti-inflammatory mediator.
St. Jude Medical (NYSE:STJ) has received European regulatory approval to begin selling the next-generation version of its Epiducer lead delivery system.
Leads are wires containing electrodes that deliver electrical shocks from neurostimulators, which use electricity to block the transmission of pain signals to the brain in patients suffering from chronic pain.
NeuroTherm added another asset to its portfolio of pain management products with yet another acquisition, this time of Smith & Nephew plc’s (NYSE:SNN) interventional spine pain management line.
The deal, for an undisclosed amount, brings Smith & Nephew’s CDS discography system, SpineCath and AcuTherm catheters and a full radiofrequency product line under Wilmington, Mass.-based NeuroTherm’s umbrella. The deal also calls for NeuroTherm to distribute Smith & Nephew’s TruCath injection system. Financial terms were not disclosed.